3D CRANI, a novel MR neurography sequence, can reliable visualise the extraforaminal cranial and occipital nerves
Open Access
- 26 November 2022
- journal article
- research article
- Published by Springer Nature in European Radiology
- Vol. 33 (4) , 2861-2870
Abstract
Objectives: We aim to validate 3D CRANI, a novel high-field STIR TSE, MR neurography sequence in the visualisation of the extraforaminal cranial and occipital nerve branches on a 3-T system. Furthermore, we wish to evaluate the role of gadolinium administration and calculate nerve benchmark values for future reference. Methods: Eleven consecutive patients underwent MR imaging including the 3D CRANI sequence before and immediately after intravenous gadolinium administration. Two observers rated suppression quality and nerve visualisation using Likert scales before and after contrast administration. Extraforaminal cranial and occipital nerves were assessed. Nerve calibers and signal intensities were measured at predefined anatomical landmarks, and apparent signal intensity ratios were calculated. Results: The assessed segments of the cranial and occipital nerves could be identified in most cases. The overall intrarater agreement was 79.2% and interrater agreement was 82.7% (intrarater κ = .561, p < .0001; interrater κ = .642, p < .0001). After contrast administration, this significantly improved to an intrarater agreement of 92.7% and interrater agreement of 93.6% (intrarater κ = .688, p < .0001; interrater κ = .727, p < .0001). Contrast administration improved suppression quality and significant changes in nerve caliber and signal intensity measurements. Nerve diameter and signal intensity benchmarking values were obtained. Conclusion: 3D CRANI is reliable for the visualization of the extraforaminal cranial and occipital nerves. Intravenous gadolinium significantly improves MR neurography when applying this sequence. Benchmarking data are published to allow future assessment of the 3D CRANI sequence in patients with pathology of the extraforaminal cranial and occipital nerves. Key Points: • MR neurography using the 3D CRANI sequence is a reliable method to evaluate the extraforaminal cranial and occipital nerves. • Gadolinium contrast administration significantly improves suppression quality and nerve visualisation. • Benchmarking values including apparent signal intensity ratios and nerve calibers depend on contrast administration and might play an important role in future studies evaluating extraforaminal cranial and occipital neuropathies.Keywords
This publication has 16 references indexed in Scilit:
- MRI of the inferior alveolar nerve and lingual nerve—anatomical variation and morphometric benchmark values of nerve diameters in healthy subjectsClinical Oral Investigations, 2019
- MR Neurographic Evaluation of Facial and Neck Pain: Normal and Abnormal Craniospinal Nerves below the Skull BaseRadioGraphics, 2018
- Magnetic Resonance Neurography of Traumatic and Nontraumatic Peripheral Trigeminal NeuropathiesJournal of Oral and Maxillofacial Surgery, 2018
- Role of MR Neurography for the Diagnosis of Peripheral Trigeminal Nerve Injuries in Patients with Prior Molar Tooth ExtractionAmerican Journal of Neuroradiology, 2017
- Clinical impact of magnetic resonance neurography in patients with brachial plexus neuropathiesBritish Journal of Radiology, 2016
- Magnetic resonance neurography in the management of peripheral trigeminal neuropathy: experience in a tertiary care centreEuropean Radiology, 2016
- Ulnar Neuropathy at the Elbow: MR Neurography—Nerve T2 Signal Increase and CaliberRadiology, 2011
- Guidelines for Reporting Reliability and Agreement Studies (GRRAS) were proposedJournal of Clinical Epidemiology, 2011
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesThe Lancet, 2007
- MRI of peripheral nerve degeneration and regeneration: correlation with electrophysiology and histologyExperimental Neurology, 2004